Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Apr 1;89(7):3070-4.
doi: 10.1073/pnas.89.7.3070.

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

Affiliations

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

A K Godwin et al. Proc Natl Acad Sci U S A. .

Abstract

Exposure of human ovarian tumor cell lines to cisplatin led to development of cell lines that exhibited increasing degrees of drug resistance, which were closely correlated with increase of the levels of cellular glutathione. Cell lines were obtained that showed 30- to 1000-fold increases in resistance; these cells also had strikingly increased (13- to 50-fold) levels of glutathione as compared with the drug-sensitive cells of origin. These levels of resistance to cisplatin and the cellular glutathione levels are substantially greater than previously reported. Very high cisplatin resistance was associated with enhanced expression of mRNAs for gamma-glutamylcysteine synthetase and gamma-glutamyl transpeptidase; immunoblots showed increase of gamma-glutamylcysteine synthetase but not of glutathione synthetase. Glutathione S-transferase activity was unaffected, as determined with chlorodinitrobenzene as a substrate. These studies suggest the potential value of examining regulation of glutathione synthesis as an indicator of clinical prognosis. The highly resistant cell lines are proving useful for studying the multiple mechanisms by which tumor cells acquire drug- and radiation-resistance.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Natl Cancer Inst. 1976 Sep;57(3):591-8 - PubMed
    1. Biochem Pharmacol. 1964 Sep;13:1291-303 - PubMed
    1. Cancer Res. 1979 Jan;39(1):269-72 - PubMed
    1. J Biol Chem. 1979 Feb 25;254(4):1205-10 - PubMed
    1. Cancer Treat Rep. 1979 Jun;63(6):1115-21 - PubMed

Publication types